STS General Thoracic Surgery Database (GTSD) Update

Similar documents
Quality metrics for resection: Are they reasonable?

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes

Minimally Invasive Esophagectomy

Thoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014

Impact of Tidal Volume on Complications after Thoracic Surgery

Determining the Optimal Surgical Approach to Esophageal Cancer

De.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): n/a

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

J. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR GENERAL THORACIC SURGERY

T3 NSCLC: Chest Wall, Diaphragm, Mediastinum

Controversies in management of squamous esophageal cancer

The STS Database is the Best Measure of Quality: CON

Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

Transhiatal Esophagectomy: Lower Mortality, Diminished Morbidity, Equal Effectiveness

The Learning Curve for Minimally Invasive Esophagectomy

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

Is surgical Apgar score an effective assessment tool for the prediction of postoperative complications in patients undergoing oesophagectomy?

Clinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer

In 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315)

Robotic Surgery for Esophageal Cancer

Hot topics in Radiation Oncology for the Primary Care Providers

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery

Mastering Thoracoscopic Upper Lobectomy

NSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes:

Management of Esophageal Cancer: Evidence Based Review of Current Guidelines. Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center

The Effect of Tidal Volume on Pulmonary Complications following Minimally Invasive Esophagectomy: A Randomized and Controlled Study

FTS Oesophagectomy: minimal research to date 3,4

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Although surgical resection is the best treatment for localized. Predictors of Postoperative Quality of Life after Surgery for Lung Cancer

1. Epidemiology of Esophageal Cancer 2. Operative Strategies 3. Minimally Invasive Esophagectomy 4. Video

New Advances in Lung Cancer

NATIONAL QUALITY FORUM

Index. Note: Page numbers of article titles are in boldface type.

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

Thoracoscopic Lobectomy: Technical Aspects in Years of Progress

DATA REPORT. August 2014

Surgical strategies in esophageal cancer

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer

General introduction and outline of thesis

Esophageal Cancer. Wesley A. Papenfuss MD FACS Surgical Oncology Aurora Cancer Care. David Demos MD Thoracic Surgery Aurora Cancer Care

Interest in minimally invasive surgical interventions, Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes

Registry Highlights. Dale Daniel Symposium Hip Fracture Registry. Overall Volume by Year and Region 3/7/2014


SETTING Fudan University Shanghai Cancer Center. RESPONSIBLE PARTY Haiquan Chen MD.

Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty

Heterogeneity of N2 disease

The Journal of Thoracic and Cardiovascular Surgery

HISTORY SURGERY FOR TUMORS WITH INVASION OF THE APEX 15/11/2018

As the proportion of the elderly in the

Yutian Lai #, Xin Wang #, Pengfei Li, Jue Li, Kun Zhou, Guowei Che. Introduction

National perioperative outcomes of pulmonary lobectomy for cancer in the obese patient: A propensity score matched analysis

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

37th Annual Toronto Thoracic Surgery Refresher Course

Esophageal cancer: Biology, natural history, staging and therapeutic options

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease

Ashleigh Clark 1, Jessica Ozdirik 2, Christopher Cao 1,2. Introduction

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds

Minimally Invasive Esophagectomy

T2N0 Esophageal Cancer: Does it Exist? Should we give Preop Therapy?

Perioperative changes of serum albumin are a predictor of postoperative pulmonary complications in lung cancer patients: a retrospective cohort study

Clinical Quality Measures for PQRS. Last Updated: June 4, 2014

Facing Surgery for Lung Cancer? Learn about minimally invasive da Vinci Surgery

Robotic lobectomy: revolution or evolution?

Robot assisted thoracic surgery: a review of current literature.

Prolonged air leak after video-assisted thoracic surgery lung cancer resection: risk factors and its effect on postoperative clinical recovery

The Influence of Surgeon Specialty on Outcomes in General Thoracic Surgery: A National Sample 1996 to 2005

Surgical Approaches to Pulmonary Metastases

STS General Thoracic Surgery Database Participant Performance for Lobectomy Compared to STS and NIS Databases

The incidence of adenocarcinoma of the esophagus

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Surgical Ablation for Lone AF: What have we learned after 30 years?

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

In the United States, 97 million overweight or obese

Minimally Invasive Esophagectomy: OVERRATED!!! Sagar Damle UCHSC December 11, 2006

Proper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer

Guidelines to standards. Orthogeriatrics How The UK Care For Fragility Fractures

Surgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09

MOLECULAR AND CLINICAL ONCOLOGY 3: , 2015

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Atrial Fibrillation Ablation Thinktank

VATS after induction therapy: Effective and Beneficial Tips on Strategy

The Impact of Body Mass Index on Esophageal Cancer

Optimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative

DATA ELEMENTS NEEDED FOR QUALITY ASSESSMENT COPYRIGHT NOTICE

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

Kawahara, Katsunobu; Tomita, Masao. Citation Acta Medica Nagasakiensia. 1992, 37

Risk Factors of Early Complications of Tracheostomy at Kenyatta National Hospital.

Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: Hospital and surgeon volume-related outcomes

A Novel Intrathoracic Esophagogastric Anastomotic Technique: Potential Benefit for Patients Undergoing a Robotic Assisted MIE

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER

The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization within the National Surgical Quality Improvement Database

The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement

POSTOPERATIVE COMPLICATIONS OF TRANSTHORACIC ESOPHAGECTOMY FOR ESOPHAGEAL CARCINOMA

Transcription:

STS General Thoracic Surgery Database (GTSD) Update Benjamin D. Kozower, MD, MPH Professor of Surgery Chair, STS GTSD Co-Director, Surgical Outcomes Research Center Washington University St. Louis, MO

GTSD: Updates Participation Risk Adjusted Model Updates Lung and esophageal cancer resection Quality composite measures Lobectomy and esophagectomy Challenges / Opportunities

GTSD Participation 300 279 Programs 250 200 150 100 50 0 2003 2005 2007 2009 2011 2013 2016

STS Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes FG Fernandez, A Kosinski, W Burfeind, B Park, MM DeCamp, C Seder, B Marshall, MJ Magee, CD Wright, BD Kozower STS General Thoracic Surgery Database Task Force Presented at the Southern Thoracic Surgical Association November 2015

General Thoracic Surgery Database (GTSD) Evolution Prior risk model: 2002-2008 Current cohort: 2012-2014 Lung Cancer resections 18,800 27,844 Centers reporting 111 231 Thoracoscopy 37% 62% Database audited No Yes* * Magee MJ et al. Ann Thorac Surg 2013

Adverse Events Operative mortality: 1.4% (401/27,844) Major morbidity 9.1% (2,545/27,844) Composite mortality or major morbidity 9.5% (2,654/27,844)

Mortality Risk Model Variable Odds Ratio (95% CI) p-value Procedure: Pneumonectomy 4.80 (2.87, 8.02) <0.001 Bilobectomy Lobectomy* 3.57 (2.09, 6.12) 1.69 (1.14, 2.53) Approach Thoracotomy* 1.87 (1.49, 2.36) <0.001 Reoperation* 1.38 (1.00, 1.94) 0.05 Induction therapy 1.51 (1.09, 2.10) 0.014 C statistic = 0.78 * - not significant in prior model

Predictors Of Major Morbidity Or Mortality After Resection For Esophageal Cancer: A Society Of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model Daniel Raymond, MD and STS GTSD Task Force 11/5/15 - STSA

Time to update the model... Increase in number of contributing centers 164 vs 73 Growth of minimally invasive esophageal procedures Transhiatal-Total esophagectomy, without thoracotomy, with cervical esophagogastrostomy (43107) Three hole-total esophagectomy with thoracotomy; with cervical esophagogastrostomy (43112) Ivor Lewis-Partial esophagectomy, distal two-thirds, with thoracotomy and separate abdominal incision (43117) Thoracoabdominal-Partial esophagectomy, thoracoabdominal approach (43122) Minimally invasive three hole esophagectomy Minimally invasive esophagectomy, Ivor Lewis approach Minimally invasive esophagectomy, Abdominal and neck approach

Results 4321 procedures 4124 for multivariable analysis due to missing data Perioperative mortality: 3.1% Perioperative morbidity ( 1): 33.1% 2/3 overweight, 3% underweight 60% former smokers; 15% active smokers

Independent Predictors of Perioperative Morbidity or Mortality OR

OR for Combined Morbidity or Mortality Procedure Type OR

Quality Composite Measures Lobectomy for lung cancer Esophagectomy for esophageal cancer In progress (Andrew Chang U. Michigan) Ann Thorac Surg. 2016; 101(4):1379-87 Submitted to STS 2017

Lobectomy for Lung Cancer Developed the first composite quality measure for thoracic surgery Lobectomy for lung cancer 2 domain measure Use 3 years of rolling data Compare hospitals with STS data along with national outcomes STS participants outperform national benchmarks

Composite Outcomes 20,657 lobectomies from 231 Participants Operative mortality 1.5% Major complications 9.6% Pneumonia 4.3% Unexpected return to OR 3.9% Reintubation 3.4% Pulmonary embolus 0.5% Initial Vent Support >48 Hours 0.5% Bronchopleural fistula 0.4% Tracheostomy 1.0% ARDS 0.7% Myocardial infarction 0.4% Length of stay (median) 4 days, IQR (3,7)

Lobectomy for Lung Cancer STS results are NOT Generalizable

GTSD: Challenges / Opportunities Increase participation Implement public reporting for GTSD Create an STS owned web based platform Enhance the value of the database

Lung Cancer Resection Volumes Small National Capture National - NIS NIS STS - GTSD GTDB 8% LaPar, Kozower. Ann Thorac Surg 2012;94:216

Increase Participation Improving Penetrance of the GTSD Lobectomy (2012) 6,925 in STS 26,015 in NIS = 26.6% Esophagectomy (2012) 1,491 in STS 5,200 in NIS = 28.7%

Increase Participation Improving Penetrance of the GTSD Need to capture the cardiac and general surgeons performing thoracic surgery Consider a lung cancer resection module Encourage primarily cardiac surgeons participating in adult cardiac STS Determine barriers to participation

Public Reporting of Surgical Outcomes Voluntary Participation: 41.7% in 2015

Thoracic Public Reporting Three Displays List of participants STS outperforms national benchmarks Compare STS with national outcomes STS database and participant comparisons Utilize the National Inpatient Sample (NIS) Star ratings

STS Database Platform Should the STS create and manage its own web based GTSD platform? Given the number of vendors with small numbers of participants, it s difficult and expensive to update the database Vendor Participants 1 96 2 32 3 31 4 27 5 15 6 13 7 8 8 6 9 5 10 4 11 1 Participant generated software 6

Enhance the Value of GTSD Audit results Overall data accuracy 94.9% (Mitch Magee) Long term follow-up Critical for evaluation of oncology outcomes 5 year survival added for lung and esophageal cancer resection CMS linkage (PI Fernandez) Exploring linkage with NCDB Patient reported outcomes Regional quality collaboration Balance goals of research and quality Increase data capture balanced with burden on data managers Leverage the database for private/industry collaboration

Thank You